Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF

Grade Last Price % Change Price Change
D 51.6 2.65% 1.33
SBIO closed up 2.65 percent on Friday, March 5, 2021, on 2.18 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical SBIO trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bullish Other 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Volume Surge Other 2.65%
Lower Bollinger Band Walk Weakness 2.65%
Multiple of Ten Bullish Other 2.65%
Below Lower BB Weakness 2.65%
Older End-of-Day Signals for SBIO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% 1 day ago
60 Minute Opening Range Breakout 1 day ago
Up 1% 1 day ago
Reversed from Down 1 day ago
Down 1 ATR 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Classification

Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management

Top 10 Components

Symbol Grade Price % Change Allocation
MRTX D 5.29 5.06
XLRN B -0.09 3.88
EBS F 1.58 3.83
ARWR D -0.81 3.44
UTHR C 2.49 3.33
MOR F 0.41 3.11
BPMC D 4.26 2.93
FGEN F 5.72 2.86
ALLK D 9.36 2.81
ARNA D 2.88 2.78
View All SBIO Holdings

Is SBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 64.04
52 Week Low 25.1
Average Volume 38,378
200-Day Moving Average 46.74
50-Day Moving Average 56.33
20-Day Moving Average 57.78
10-Day Moving Average 54.73
Average True Range 2.19
ADX 36.3
+DI 13.69
-DI 44.51
Chandelier Exit (Long, 3 ATRs ) 57.48
Chandelier Exit (Short, 3 ATRs ) 54.52
Upper Bollinger Band 65.10
Lower Bollinger Band 50.46
Percent B (%b) 0.08
BandWidth 25.33
MACD Line -1.35
MACD Signal Line -0.31
MACD Histogram -1.0341
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.08
Resistance 3 (R3) 56.47 54.04 56.16
Resistance 2 (R2) 54.04 52.65 54.34 55.86
Resistance 1 (R1) 52.82 51.78 53.43 53.43 55.55
Pivot Point 50.39 50.39 50.70 50.69 50.39
Support 1 (S1) 49.17 49.00 49.78 49.78 47.65
Support 2 (S2) 46.74 48.13 47.04 47.34
Support 3 (S3) 45.52 46.74 47.04
Support 4 (S4) 46.13